Early phase cancer clinical trials: design, ethics and future directions

Nicholas Coupe1, Avinash Gupta2, Simon R Lord3

  • 1Clinical Research Fellow in Medical Oncology.

Insights

Early phase cancer trials determine optimal drug dosage. Study designs are evolving to focus on molecularly targeted agents in cancer drug development.

Area of Science:

  • Oncology
  • Clinical Pharmacology
  • Drug Development

Background:

  • Early phase clinical trials are crucial for establishing the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2D) for novel cancer therapeutics.
  • Traditional dose-escalation designs are well-established but may not be optimal for all new drug classes.

Purpose of the Study:

  • To describe the evolving role of early phase clinical trials in cancer research.
  • To highlight the impact of molecularly targeted agents on trial design.

Main Methods:

  • Review of current early phase clinical trial designs.
  • Analysis of how drug development trends influence study methodologies.
  • Discussion of adaptive and novel trial designs.

Main Results:

  • The primary objective of dose determination remains central to early phase trials.
  • A shift towards incorporating molecular profiling and targeted therapies necessitates design modifications.
  • Newer designs aim for greater efficiency and earlier assessment of efficacy signals.

Conclusions:

  • Early phase cancer trial designs are adapting to the era of precision medicine.
  • Future trials will increasingly integrate molecularly targeted agents and potentially novel designs to optimize drug development pathways.

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
11.2K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.5K
Nursing Ethical Principles II01:27

Nursing Ethical Principles II

Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
2.6K
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
838